The use of virosomes as a vaccine platform has proven successful against several viruses. Here we examined the protective efficacy of a virosome-based vaccine consisting of avian influenza virus (AIV) A/Duck/Czech/56/H4N6 in chickens against a homologous AIV challenge. Virosomes adjuvanted with CpG-ODN or recombinant chicken interferon (IFN)-γ significantly reduced virus shedding after virus challenge. Furthermore, immunization with virosomes adjuvanted with CpG-ODN increased hemagglutination inhibition (HI) and virus-specific neutralizing serum antibodies, as well as virus-specific serum IgG and mucosal IgA responses. We also found a significant increase in the expression of type I and II interferon genes in the protected birds following virus challenge. In summary, this study demonstrated the ability of virosomes adjuvanted with CpG-ODN to reduce AIV shedding, and elicit virus-specific protective antibody responses in vaccinated birds.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/vim.2011.0085 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Understanding Mucosal Physiology and Rationale of Formulation Design for Improved Mucosal Immunity.
ACS Appl Bio Mater
August 2024
Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, El Paso, Texas 79902, United States.
The oral and nasal cavities serve as critical gateways for infectious pathogens, with microorganisms primarily gaining entry through these routes. Our first line of defense against these invaders is the mucosal membrane, a protective barrier that shields the body's internal systems from infection while also contributing to vital functions like air and nutrient intake. One of the key features of this mucosal barrier is its ability to protect the physiological system from pathogens.
View Article and Find Full Text PDFNanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines.
Vaccines (Basel)
June 2023
Department of Pharmaceutical Technology and Cosmetology, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, Serbia.
Ever since the development of the first vaccine, vaccination has had the great impact on global health, leading to the decrease in the burden of numerous infectious diseases. However, there is a constant need to improve existing vaccines and develop new vaccination strategies and vaccine platforms that induce a broader immune response compared to traditional vaccines. Modern vaccines tend to rely on certain nanotechnology platforms but are still expected to be readily available and easy for large-scale manufacturing and to induce a durable immune response.
View Article and Find Full Text PDFEnhanced HPV16 E6/E7 tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides.
Cancer Immunol Immunother
August 2023
ISA Pharmaceuticals BV, De Limes 7, 2342 DH, Oegstgeest, The Netherlands.
Therapeutic cancer vaccines trigger CD4 + and CD8 + T cell responses capable of established tumor eradication. Current platforms include DNA, mRNA and synthetic long peptide (SLP) vaccines, all aiming at robust T cell responses. SLPs linked to the Amplivant® adjuvant (Amplivant-SLP) have shown effective delivery to dendritic cells, resulting in improved immunogenicity in mice.
View Article and Find Full Text PDFVirosome: An engineered virus for vaccine delivery.
Saudi Pharm J
May 2023
Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
purpose of immunization is the effective cellular and humoral immune response against antigens. Several studies on novel vaccin delivery approaches such as micro-particles, liposomes & nanoparticles, etc against infectious diseases have been investigated so far. In contrast to the conventional approaches in vaccin development, a virosomeased vaccine represent the next generation in the field of immunization because of its balance betweefficacy and tolerability by virtue of mechanism of immune instigation.
View Article and Find Full Text PDFAdvances in intranasal vaccine delivery: A promising non-invasive route of immunization.
Vaccine
June 2023
Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15784, Greece.
The importance of vaccination has been proven particularly significant the last three years, as it is revealed to be the most efficient weapon for the prevention of several infections including SARS-COV-2. Parenteral vaccination is the most applicable method of immunization, for the prevention of systematic and respiratory infections, or central nervous system disorders, involving T and B cells to a whole-body immune response. However, the mucosal vaccines, such as nasal vaccines, can additionally activate the immune cells localized on the mucosal tissue of the upper and lower respiratory tract.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!